Dr. McKay Discusses Immunotherapy Trials in RCC – OncLive
|
Dr. McKay Discusses Immunotherapy Trials in RCC
OncLive Rana R. McKay, MD, medical oncologist, assistant professor, Moores Cancer Center at the University of California, San Diego, discusses immunotherapy trials in renal cell carcinoma (RCC). Data presented at the 2017 ESMO Congress showed that the … |
